Agios Pharmaceuticals, Inc. (AGIO)
Agios Pharmaceuticals Market Cap : 1.765B for Feb. 23, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Dynavax Technologies Corp. (DELISTED) | 1.820B |
| Gilead Sciences, Inc. | 187.75B |
| CorMedix, Inc. | 557.04M |
| Alnylam Pharmaceuticals, Inc. | 44.24B |
| Enanta Pharmaceuticals, Inc. | 402.06M |
Market Cap Related Metrics
| PS Ratio | 32.33 |
| Price to Book Value | 1.480 |
| Price | 30.13 |
| Earnings Yield | -23.63% |